Brief: Generation Bio Reports Q1 2022 Results
May 5 (Reuters) - Generation Bio Co GBIO.O :
* GENERATION BIO REPORTS BUSINESS HIGHLIGHTS AND FIRST
QUARTER
2022 FINANCIAL RESULTS
* CASH BALANCE OF $337.0M EXPECTED TO FUND OPERATIONS INTO
2024
* NET LOSS WAS $35.0 MILLION, OR $0.61 BASIC AND DILUTED NET
LOSS
PER SHARE, FOR QUARTER ENDED MARCH 31, 2022
* Q1 EARNINGS PER SHARE VIEW $-0.53 -- REFINITIV IBES DATA
Source text for Eikon: ID:nGNX7FvrBh
Further company coverage: GBIO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Generation Bio
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT CONTINUES TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 03:28 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Nodthera Appoints Geoff Mcdonough, M.D., As Independent Board Member